These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 27593744)

  • 21. Clinical outcomes using ClearPoint interventional MRI for deep brain stimulation lead placement in Parkinson's disease.
    Ostrem JL; Ziman N; Galifianakis NB; Starr PA; Luciano MS; Katz M; Racine CA; Martin AJ; Markun LC; Larson PS
    J Neurosurg; 2016 Apr; 124(4):908-16. PubMed ID: 26495947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease.
    Yamamoto T; Uchiyama T; Higuchi Y; Asahina M; Hirano S; Yamanaka Y; Kuwabara S
    PLoS One; 2015; 10(9):e0138462. PubMed ID: 26394059
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease.
    Anderson VC; Burchiel KJ; Hogarth P; Favre J; Hammerstad JP
    Arch Neurol; 2005 Apr; 62(4):554-60. PubMed ID: 15824252
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unilateral pallidotomy versus bilateral subthalamic nucleus stimulation in PD: a randomized trial.
    Esselink RA; de Bie RM; de Haan RJ; Lenders MW; Nijssen PC; Staal MJ; Smeding HM; Schuurman PR; Bosch DA; Speelman JD
    Neurology; 2004 Jan; 62(2):201-7. PubMed ID: 14745054
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Globus pallidus stimulation in advanced Parkinson's disease.
    Rodrigues JP; Walters SE; Watson P; Stell R; Mastaglia FL
    J Clin Neurosci; 2007 Mar; 14(3):208-15. PubMed ID: 17150360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Levodopa withdrawal after bilateral subthalamic nucleus stimulation in advanced Parkinson disease.
    Molinuevo JL; Valldeoriola F; Tolosa E; Rumia J; Valls-Sole J; Roldan H; Ferrer E
    Arch Neurol; 2000 Jul; 57(7):983-8. PubMed ID: 10891980
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical predictive factors of subthalamic stimulation in Parkinson's disease.
    Welter ML; Houeto JL; Tezenas du Montcel S; Mesnage V; Bonnet AM; Pillon B; Arnulf I; Pidoux B; Dormont D; Cornu P; Agid Y
    Brain; 2002 Mar; 125(Pt 3):575-83. PubMed ID: 11872614
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Different effectiveness of subthalamic deep brain stimulation in Parkinson's disease: A comparative cohort study at 1 year and 5 years.
    Jiang JL; Chen SY; Hsieh TC; Lee CW; Lin SH; Tsai ST
    J Formos Med Assoc; 2015 Sep; 114(9):835-41. PubMed ID: 24103710
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medication dose reductions after pallidal versus subthalamic stimulation in patients with Parkinson's disease.
    Evidente VG; Premkumar AP; Adler CH; Caviness JN; Driver-Dunckley E; Lyons MK
    Acta Neurol Scand; 2011 Sep; 124(3):211-4. PubMed ID: 20969559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of bilateral subthalamic nucleus stimulation on levodopa-unresponsive axial symptoms in Parkinson's disease.
    Yamada K; Goto S; Hamasaki T; Kuratsu JI
    Acta Neurochir (Wien); 2008 Jan; 150(1):15-22; discussion 22. PubMed ID: 18180867
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Staged bilateral deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease.
    Tanei T; Kajita Y; Kaneoke Y; Takebayashi S; Nakatsubo D; Wakabayashi T
    Acta Neurochir (Wien); 2009 Jun; 151(6):589-94. PubMed ID: 19381434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stimulation of the subthalamic nucleus in Parkinson's disease: a 5 year follow up.
    Schüpbach WM; Chastan N; Welter ML; Houeto JL; Mesnage V; Bonnet AM; Czernecki V; Maltête D; Hartmann A; Mallet L; Pidoux B; Dormont D; Navarro S; Cornu P; Mallet A; Agid Y
    J Neurol Neurosurg Psychiatry; 2005 Dec; 76(12):1640-4. PubMed ID: 16291886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subthalamic nucleus stimulation does not cause deterioration of preexisting hallucinations in Parkinson's disease patients.
    Yoshida F; Miyagi Y; Kishimoto J; Morioka T; Murakami N; Hashiguchi K; Samura K; Sakae N; Yamasaki R; Kawaguchi M; Sasaki T
    Stereotact Funct Neurosurg; 2009; 87(1):45-9. PubMed ID: 19174620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deep brain stimulation of the subthalamic nucleus for advanced Parkinson disease using general anesthesia: long-term results.
    Harries AM; Kausar J; Roberts SA; Mocroft AP; Hodson JA; Pall HS; Mitchell RD
    J Neurosurg; 2012 Jan; 116(1):107-13. PubMed ID: 21999316
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quality of life in advanced Parkinson's disease after bilateral subthalamic stimulation: 2 years follow-up study.
    Sobstyl M; Ząbek M; Górecki W; Mossakowski Z
    Clin Neurol Neurosurg; 2014 Sep; 124():161-5. PubMed ID: 25051167
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcome of bilateral subthalamic nucleus stimulation in the treatment of Parkinson's disease: correlation with intra-operative multi-unit recordings but not with the type of anaesthesia.
    Lefaucheur JP; Gurruchaga JM; Pollin B; von Raison F; Mohsen N; Shin M; Ménard-Lefaucheur I; Oshino S; Kishima H; Fénelon G; Rémy P; Cesaro P; Gabriel I; Brugières P; Keravel Y; Nguyen JP
    Eur Neurol; 2008; 60(4):186-99. PubMed ID: 18667827
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subthalamic stimulation in Parkinson's disease: restoring the balance of motivated behaviours.
    Lhommée E; Klinger H; Thobois S; Schmitt E; Ardouin C; Bichon A; Kistner A; Fraix V; Xie J; Aya Kombo M; Chabardès S; Seigneuret E; Benabid AL; Mertens P; Polo G; Carnicella S; Quesada JL; Bosson JL; Broussolle E; Pollak P; Krack P
    Brain; 2012 May; 135(Pt 5):1463-77. PubMed ID: 22508959
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of bilateral subthalamic nucleus (STN) stimulation in Parkinson's disease.
    Erola T; Heikkinen ER; Haapaniemi T; Tuominen J; Juolasmaa A; Myllylä VV
    Acta Neurochir (Wien); 2006 Apr; 148(4):389-94. PubMed ID: 16284705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bilateral effects of unilateral subthalamic deep brain stimulation on Parkinson's disease at 1 year.
    Walker HC; Watts RL; Guthrie S; Wang D; Guthrie BL
    Neurosurgery; 2009 Aug; 65(2):302-9; discussion 309-10. PubMed ID: 19625909
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term effects of bilateral subthalamic nucleus stimulation in advanced Parkinson disease: a four year follow-up study.
    Visser-Vandewalle V; van der Linden C; Temel Y; Celik H; Ackermans L; Spincemaille G; Caemaert J
    Parkinsonism Relat Disord; 2005 May; 11(3):157-65. PubMed ID: 15823480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.